Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods

O. Mayer (United States of America)

Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Session: New ideas for the management of chronic lung diseases
Session type: Oral Presentation
Number: 2928
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Mayer (United States of America). Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods. 2928

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017



Inefficient cough in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD)
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018

Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019




Respiratory kinematics in Duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2007; 30: Suppl. 51, 376s
Year: 2007

Implication of regular pulmonary function evaluation in Duchenne muscular dystrophy
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Which are the most informative parameters to follow the respiratory decline in Duchenne muscular dystrophy?
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Respiratory muscle testing: a valuable tool for young patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: Suppl. 50, 357s
Year: 2006

Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood
Source: Eur Respir J, 51 (2) 1701418; 10.1183/13993003.01418-2017
Year: 2018



Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference?
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001

Observation cohort study of cause of death in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012


Assessment of diaphragm thickness variations by ultrasonography in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

The natural course of lung volumes in Duchenne Muscular Dystrophy (DMD)
Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children
Year: 2017

Ventilatory assistance in patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: 468-469
Year: 2006


Characterization and survival in Duchenne muscular dystrophy with non-invasive ventilation in Chile
Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure
Year: 2017


Effect of steroid therapy on lung volumes in duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Gastrointestinal dysfunction in ventilated patients with Duchenne muscular dystrophy
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012

Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD)
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019




Pulmonary function in Duchenne muscular dystrophy patients before and after noninvasive ventilation
Source: Eur Respir J 2005; 26: Suppl. 49, 85s
Year: 2005